Reata Pharmaceuticals, Inc. RETA
172.36 +172.36
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 2.22M | 11.49M | 9.02M | 26.52M | 53.59M | |
| 2.22M | 11.49M | 9.02M | 26.52M | 53.59M | |
| 2.22M | 11.49M | 9.02M | 26.52M | 53.59M | |
| 280.25M | 256.20M | 235.34M | 311.74M | 130.47M | |
| 169.84M | 155.99M | 159.08M | 128.11M | 97.29M | |
| 109.28M | 99.00M | 75.13M | 58.30M | 32.75M | |
| -278.03M | -244.71M | -226.32M | -285.22M | -76.88M | |
| 33.89M | 53.13M | 43.91M | 4.94M | 3.64M | |
| -25.00K | -450.00K | -22.49M | 8.00K | 26.00K | |
| -311.90M | -297.39M | -247.75M | -290.17M | -80.55M | |
| -311.90M | -297.39M | -247.75M | -290.17M | -80.55M | |
| -311.90M | -297.39M | -247.75M | -290.17M | -80.55M | |
| -311.90M | -297.39M | -247.75M | -290.17M | -80.55M | |
| -8.54 | -8.19 | -7.35 | -9.54 | -2.91 | |
| -8.54 | -8.19 | -7.35 | -9.54 | -2.91 | |
| -8.54 | -8.19 | -7.35 | -9.54 | -2.91 | |
| -278.03M | -244.71M | -226.32M | -285.22M | -76.88M | |
| -278.03M | -244.71M | -226.32M | -285.22M | -76.88M | |
| 36.52M | 36.32M | 33.71M | 30.41M | 27.70M | |
| 36.52M | 36.32M | 33.71M | 30.41M | 27.70M |